The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
Open Access
- 12 February 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 124 (8), 1829-1840
- https://doi.org/10.1002/ijc.24146
Abstract
The Karyopherin proteins are involved in nucleo‐cytoplasmic trafficking and are critical for protein and RNA subcellular localization. Recent studies suggest they are important in nuclear envelope component assembly, mitosis and replication. Since these are all critical cellular functions, alterations in the expression of the Karyopherins may have an impact on the biology of cancer cells. In this study, we examined the expression of the Karyopherins, Crm1, Karyopherin β1 (Kpnβ1) and Karyopherin α2 (Kpnα2), in cervical tissue and cell lines. The functional significance of these proteins to cancer cells was investigated using individual siRNAs to inhibit their expression. Microarrays, quantitative RT‐PCR and immunofluorescence revealed significantly higher expression of Crm1, Kpnβ1 and Kpnα2 in cervical cancer compared to normal tissue. Expression levels were similarly elevated in cervical cancer cell lines compared to normal cells, and in transformed epithelial and fibroblast cells. Inhibition of Crm1 and Kpnβ1 in cancer cells significantly reduced cell proliferation, while Kpnα2 inhibition had no effect. Noncancer cells were unaffected by the inhibition of Crm1 and Kpnβ1. The reduction in proliferation of cancer cells was associated with an increase in a subG1 population by cell cycle analysis and Caspase‐3/7 assays revealed increased apoptosis. Crm1 and Kpnβ1 siRNA‐induced apoptosis was accompanied by an increase in the levels of growth inhibitory proteins, p53, p27, p21 and p18. Our results demonstrate that Crm1, Kpnβ1 and Kpnα2 are overexpressed in cervical cancer and that inhibiting the expression of Crm1 and Kpnβ1, not Kpnα2, induces cancer cell death, making Crm1 and Kpnβ1 promising candidates as both biomarkers and potential anticancer therapeutic targets.This publication has 50 references indexed in Scilit:
- Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenesInternational Journal of Cancer, 2007
- The L2 Minor Capsid Protein of Low-Risk Human Papillomavirus Type 11 Interacts with Host Nuclear Import Receptors and Viral DNAJournal of Virology, 2006
- Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast CancerClinical Cancer Research, 2006
- Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeJNCI Journal of the National Cancer Institute, 2006
- Regulation of Nuclear Transport: Central Role in Development and Transformation?Traffic, 2005
- Nuclear transport and cancer: from mechanism to interventionNature Reviews Cancer, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Accumulating Active p53 in the Nucleus by Inhibition of Nuclear Export: A Novel Strategy to Promote the p53 Tumor Suppressor FunctionExperimental Cell Research, 1999
- Nucleocytoplasmic TransportScience, 1996